Projects per year
Fingerprint
Dive into the research topics where Anna Vilgelm is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Active
-
A phase-1 trial of intraperitoneal 5-fluorouracil and oxaliplatin in patients with colorectal cancer and unresectable peritoneal metastasis.
Mittra, A., Kim, A. A. C. & Vilgelm, A.
09/12/23 → 08/31/25
Project: Research
-
Combining senescence-inducing and senolytic agents to improve melanoma therapy
Vilgelm, A. & Vilgelm, A. E.
12/1/18 → 11/30/24
Project: Research
-
Dendritic cell therapy augments antitumor immunity triggered by CDK4/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses
Kumar, A., Ramani, V., Bharti, V., De Lima Bellan, D., Saleh, N., Uzhachenko, R., Shen, C., Arteaga, C., Richmond, A., Reddy, S. M. & Vilgelm, A., May 25 2023, In: Journal for ImmunoTherapy of Cancer. 11, 5Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Generation of Orthotopic Patient-Derived Xenografts in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for Melanoma
Yan, C., Nebhan, C. A., Saleh, N., Shattuck-Brandt, R., Chen, S. C., Ayers, G. D., Weiss, V., Richmond, A. & Vilgelm, A. E., Jul 2023, In: Cancers. 15, 14, 3695.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Illuminating the mechanism of IL-6-mediated immunotherapy resistance
Vilgelm, A. E., Jan 17 2023, In: Cell Reports Medicine. 4, 1, 100901.Research output: Contribution to journal › Comment/debate
Open Access4 Scopus citations -
BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis
Bharti, V., Watkins, R., Kumar, A., Shattuck-Brandt, R. L., Mossing, A., Mittra, A., Shen, C., Tsung, A., Davies, A. E., Hanel, W., Reneau, J. C., Chung, C., Sizemore, G. M., Richmond, A., Weiss, V. L. & Vilgelm, A. E., Dec 20 2022, In: Cell Reports. 41, 12, 111826.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations -
Personalized cancer immunotherapy
Kumar, A., Vilgelm, A. E. & Weller, K. P., Jan 1 2022, Engineering Technologies and Clinical Translation: Volume 3 of Delivery Strategies and Engineering Technologies in Cancer Immunotherapy. Elsevier, p. 399-426 28 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review